Article
Nuclear receptor binding SET domain protein 1 promotes epithelial-mesenchymal transition in paclitaxel-resistant breast cancer cells via regulating nuclear factor kappa B and F-box and leucine-rich repeat protein 11.
Bioengineered - 1 Dec 2021
Chen Yi, Tang Weiwei, Zhu Xuedan, Zhang Lele, Zhu Yinxing, Xiao Hua, Xu Jin, Fang Yueyu, Li Xiao, Tang Cuiju, Shi Junfeng
Abstract excerpt
Breast cancer (BC) is regarded as the major cause of cancer-associated deaths in women. Paclitaxel exerts a critical impact on the chemotherapy of BC, but the resistance to paclitaxel becomes a great obstacle in treating the disease. It is reported that noncoding RNA nuclear receptor binding SET domain protein 1 (NSD1) plays a significant role in drug resistance; however, the special role of NSD1 in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
